SACRAMENTO — A new gold rush is poised to begin in California, where scientists and an eager biotech industry are preparing to stake their claim to a share of $3 billion in voter-approved funding for stem cell research that many hope will lead to a trove of scientific discoveries and medical breakthroughs. (Login required.)
Office of Strategic Communication